JCRB0220 NTI-4
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB0220 | Cell Name | NTI-4 |
---|---|---|---|
Profile | Normal human fibroblast. | Other Name | NTI-4 |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | Age | 9-week fetus | |
Identity | available | Tissue for Primary Cancer | embryo |
Case history | normal | Metastasis | |
Tissue Metastasized | Genetics | fetus, half body, bottom/fibroblast | |
Life Span | finite | Crisis PDL | |
Morphology | fibroblast-like | Character | fetus, half body, bottom/fibroblast |
Classify | Established by | Inui,N. | |
Registered by | Egashira,Y. | Regulation for Distribution | |
Comment | Year | 1986 | |
Medium | Dulbecco's modified Eagle's medium with 10% fetal calf serum | Methods for Passages | Cells are treated with 0.25% trypsin. |
Cell Number on Passage | 2x10^4 cells/ml | Race | Japanese |
CO2 Conc. | 5 % | Tissue Sampling | fetus body |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Images |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
LOT Information
Cell No. | JCRB0220 | Cell Name | |
---|---|---|---|
LOT No. | 01112008 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium with 10% fetal bovine serum (FBS Lot; GIBCO 484375) | Temperature | 37 C |
Cell Density at Seeding | 4 x 10^4 cells/ml | Methods for Passages | 0.25% trypsin and 0.02% EDTA |
Doubling Time | approx. 20 hrs | Cell Number in Vial (cells/1ml) | 7 x 10^5 |
Viability at cell freezing (%) | 83 | Antibiotics Used | free |
Passage Number | P18 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), LD |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - DMEM | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0220 | Cell Name | |
---|---|---|---|
LOT No. | 042592 | Lot Specification | distribution |
Medium | DMDM : 10% FCS | Temperature | 37 |
Cell Density at Seeding | Methods for Passages | 0.25% trypsin | |
Doubling Time | Cell Number in Vial (cells/1ml) | ||
Viability at cell freezing (%) | Antibiotics Used | ||
Passage Number | PDL | ||
Sterility: MYCOPLASMA | Sterility: BACTERIA | ||
Sterility: FUNGI | Isozyme Analysis | ||
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0220 | Cell Name | NTI-4 |
---|---|---|---|
LOT No. | 04162024 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium with 10% fetal bovine serum (FBS; Nichirei Cat. # 174112, Lot 20M00K) | Temperature | 37 C |
Cell Density at Seeding | 4.4 - 9.1 x 10^4 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | approx. 1 day | Cell Number in Vial (cells/1ml) | 3.6 x 10^6 |
Viability at cell freezing (%) | 90 | Antibiotics Used | free |
Passage Number | P19 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:10,12 D13S317:8 D7S820:9,10 D16S539:9,12 VWA:16,19 TH01:7,8 AM:X TPOX:8 CSF1PO:10,11 |
|
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - DMEM | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 90 | Additional information |